Organisation paid for research Program year 2024 Source: CMS Open Payments

Women Under Study

Neither a doctor nor a teaching hospital

Research payments

$349,010

77 payments

Through program year 2024, Women Under Study is reported as receiving $349,010 in research payments, across 77 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2024	Research	$40,697	6
2021	Research	$36,810	18
2020	Research	$96,068	24
2019	Research	$175,434	29

Breakdown

Who paid Research payments · program years 2019–2024

AbbVie, Inc. $301,122 70 payments
Braintree Laboratories, Inc. $40,697 6 payments
Celgene Corporation $7,190 1 payment

Studies the money was for Research payments · program years 2019–2024

M16-283 $167,419 25 payments
M14-702 $95,767 25 payments
A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroesophageal Reflux Disease $40,697 6 payments
A Phase 3b Study to Evaluate the Long-Term Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women $26,692 9 payments
A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain $10,118 9 payments
PhIII Yellowstone Induction Study # 1 OZANIMOD in Moderate to Severe CD (RPC01-3201) (BMS Study Number: IM047-P14) $7,190 1 payment
M12-817 $1,126 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.